Efficacy/Safety of HA Inhalation Solution for Hereditary Emphysema in Patients With Alpha-1 Antitrypsin Deficiency
Status:
Completed
Trial end date:
2019-11-12
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety and efficacy of administering repeated
doses of Hyaluronic Acid Inhalation Solution to subjects with Emphysema that have
Alpha-1-Antitrypsin deficiency
Phase:
Phase 2
Details
Lead Sponsor:
Gerard Turino
Treatments:
Alpha 1-Antitrypsin Hyaluronic Acid Pharmaceutical Solutions Protein C Inhibitor